Show simple item record

dc.contributor.authorArmitage, Rachelen
dc.contributor.authorLawson, Grahamen
dc.contributor.authorTanna, Sangeetaen
dc.date.accessioned2018-03-29T13:24:58Z
dc.date.available2018-03-29T13:24:58Z
dc.date.issued2017-09-05
dc.identifier.citationArmitage R, Lawson G, Tanna S. (2017) Counterfeit or just poor quality control? APS 8th International PharmSci Conference. Hatfield, UK. 5-8 September 2017.en
dc.identifier.urihttp://hdl.handle.net/2086/15707
dc.description.abstractCounterfeit medicines are a major public health issue. The World Health Organisation suggests that the occurrence of counterfeits range from 1% in high income countries to as much as ~30-40% in low to middle income countries, however many of these may be substandard rather than counterfeit due to poor quality control. This research investigates the potential of Attenuated Total Reflectance Fourier Transform Infrared (ATR FTIR) techniques to provide rapid quantitative analysis of suspect tablet formulations. Sample preparation for ATR FTIR is minimal and only requires a single tablet to be ground to a fine powder prior to analysis. This enables more rapid analysis of tablets. Reference spectra of the active pharmaceutical ingredient (API) and excipients were recorded for identification purposes. Using atenolol as a model, quantitative data was obtained from calibrated mixtures of API and excipients. Tablets from various countries, India, Saudi Arabia, Nepal and UK were analysed using both ATR FTIR and reference UV analyses. Results demonstrated that the API was detectable down to ca 5% w/w of the tablet. Several examples of poor dosage quality control were identified.en
dc.language.isoenen
dc.publisherAPSen
dc.subjectCounterfeit medicinesen
dc.subjectATR-FTIR spectroscopyen
dc.subjectPharmaceutical analysisen
dc.subjectQuality assurance of medicinesen
dc.subjectGreen methoden
dc.subjectAtenololen
dc.titleCounterfeit or just poor quality?en
dc.typeConferenceen
dc.researchgroupPharmacy Practiceen
dc.peerreviewedYesen
dc.explorer.multimediaNoen
dc.funderN/Aen
dc.projectidN/Aen
dc.cclicenceN/Aen
dc.date.acceptance2017-09-05en
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record